A joint venture between the Spanish Esteve Group and China's Huadong Medicine Group, Esteve Huayi Pharmaceutical serves as an industrial platform in China supplying demanding API markets in the US, EU and Japan, as well as the growing Chinese domestic market. The company specializes in developing, manufacturing and commercializing APIs and high-value advanced intermediates, offering custom synthesis and toll manufacturing from cGMP-compliant kilo labs to commercial production, backed by expertise across a variety of reaction types and a highly qualified professional team.
댓글이 없습니다.
평가 & 댓글 남기기